TNFSF13B and clostridium difficile infection: In our in vivo study with the murine CDI model, fidaxomicin exposure resulted in the downregulation of RNA expression of APRIL and BAFF; the fidaxomicin monotherapy and combination therapy groups showed similar RNA expression levels on day 8 (Fig. 5C).